When it starts, the retail buyer/trader will be clueless as always.
Sure, as the market goes, so goes "most" stocks, but not always and this stock's massive sell off is due to other variables besides the market.
is that no one knows for sure about this stock.
I like your thinking but the critical PPS has historically been around $50, both technically and psychologically. If it holds $50, as it currently is, and volume carries it up in the coming week it should most definitely eclipse $60.
I'm very impressed with the infrastructure that is being creating, both from a product development and marketing development standpoint. XON is shooting for the stars.
"Celladon Corporation (CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy..." do tell!